Disease modification and Parkinson’s disease: Clinical trial design and population selection • 2025 MDS Congress
Prof. Tanya Simuni reviews the history and challenges of disease-modifying trials for Parkinson's disease, emphasizing the need for biological definitions and effective clinical trial design.